Skip to content
CancerIndex

Publication

ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.

Authors not recorded

Haematologica2013PMID 23585524PMC3696617stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (19)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 19

Curated evidence

Evidence citing this paper (24)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
23585524
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–24 of 24 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
ATM A2062V1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2846

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the A2062V variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM A2274T1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance—submitted
EID2848

In an in vitro study using primary chronic lymphocytic leukemia (CLL) cells from patients with mutated (n=8) and wildtype (n=5) ATM, inhibition of cell growth was used as an assay to determine sensiti… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM C2488Y1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2849

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the C2488Y variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM c.7089+1del1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2830

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the c.7089+1del variant on ATM expression was tested by … (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM c.7515+1_2del1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2831

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the c.7515+1_2del variant on ATM expression was tested b… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM c.902-1G>T1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2224

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the c.902-1G>T variant on ATM expression was tested by w… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM D1682H1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2845

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the D1682H variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM D1930V1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance2accepted
EID2837

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the D1930V variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM E2187*1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2839

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the E2187* variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM F1025L1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2835

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the F1025L variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM F2732V1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2841

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the F2732V variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM K293*1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2832

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the K293* variant on ATM expression was tested by wester… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM K468FS1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDDoes Not Support Resistance2accepted
EID2843

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the K468FS variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM L2427P1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2840

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the L2427P variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM Mutation1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance4accepted
EID2222

Primary cells from chronic lymphocytic leukemia patients were treated with doxorubicin to induce double-strand (DSB). In this setting, cells harboring rare ATM variants (n=8) had significantly higher … (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM Q1084*1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance—submitted
EID2836

In an in vitro study using primary chronic lymphocytic leukemia (CLL) cells from patients with mutated (n=8) and wildtype (n=5) ATM, inhibition of cell growth was used as an assay to determine sensiti… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM Q984E1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance—submitted
EID2834

In an in vitro study using primary chronic lymphocytic leukemia (CLL) cells from patients with mutated (n=8) and wildtype (n=5) ATM, inhibition of cell growth was used as an assay to determine sensiti… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM R1575H1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance—submitted
EID2847

In an in vitro study using primary chronic lymphocytic leukemia (CLL) cells from patients with mutated (n=8) and wildtype (n=5) ATM, inhibition of cell growth was used as an assay to determine sensiti… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM R2034P1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance—submitted
EID2838

In an in vitro study using primary chronic lymphocytic leukemia (CLL) cells from patients with mutated (n=8) and wildtype (n=5) ATM, inhibition of cell growth was used as an assay to determine sensiti… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM R2459C1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance—submitted
EID2833

In an in vitro study using primary chronic lymphocytic leukemia (CLL) cells from patients with mutated (n=8) and wildtype (n=5) ATM, inhibition of cell growth was used as an assay to determine sensiti… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM R3008C1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2223

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. The effect of the R3008C variant on ATM expression was tested by weste… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM R777FS1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance—submitted
EID2842

In an in vitro study using primary chronic lymphocytic leukemia (CLL) cells from patients with mutated (n=8) and wildtype (n=5) ATM, inhibition of cell growth was used as an assay to determine sensiti… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM T2666A1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance3accepted
EID2221

Primary peripheral blood mononuclear cells were taken from chronic lymphocytic leukemia patients, some of whom had prior therapy. Cells were treated with doxorubicin to induce double-strand (DSB) and … (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic
ATM V1268FS1
DoxorubicinChronic Lymphocytic LeukemiaPredictiveDSupports Resistance—submitted
EID2844

In an in vitro study using primary chronic lymphocytic leukemia (CLL) cells from patients with mutated (n=8) and wildtype (n=5) ATM, inhibition of cell growth was used as an assay to determine sensiti… (full text at CIViC)

PMID 23585524 · Navrkalova et al., 2013 · Open in CIViC

civic